生物使用对牛皮关节炎发展的影响:基于人口的研究
Kathleen L Miao1, Margaret Y Huang2, Lily Guo3
1Keck School of Medicine of USC, Los Angeles, California, USA.
概括
与单独继续光疗相比,牛皮的生物治疗显著降低了牛皮性关节炎的发生率. 这些发现表明,生物药物可能有助于预防或延迟牛皮患者的牛皮关节炎发展.
科学领域:
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
- 临床流行病学临床流行病学
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,通常在牛皮关节炎之前发生.
- 关于牛皮的生物疗法是否能预防或延缓牛皮性关节炎 (PsA) 的证据是相互矛盾的.
研究的目的:
- 调查牛皮的生物治疗与牛皮性关节炎的发病率之间的关联.
主要方法:
- 使用非识别索赔数据的回顾性队列研究 (2007-2024年).
- 鉴定了通过光疗治疗中度至重度牛皮的患者.
- 将转换为生物药物的患者与继续光疗的患者之间的PsA发病率进行比较.
主要成果:
- 生物治疗与牛皮关节炎的发病率较低有关 (调整HR,0.66;95%CI,0.53至0.83).
- 在生物队列中,发生率为每1000人年6.75,仅在光疗队列中为8.06.
结论:
- 开始治疗牛皮的生物疗法与牛皮性关节炎的发病率降低有关.
- 生物治疗可能提供一种策略,以延迟或预防牛皮患者的牛皮关节炎.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
470
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
470
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659
Drug Products: Biologics, Biosimilars and Interchangeables
223
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
223
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
473
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
473


